Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Point-of-Care PGx Test Enables Rapid Appropriate Antiplatelet Prescription for Stroke Patients

By LabMedica International staff writers
Posted on 12 Jun 2025

Clopidogrel is an antiplatelet treatment for secondary prevention of minor strokes and transient ischemic attack (TIA), also known as a mini-stroke. More...

CYP2C19 intermediate and poor metabolizers who receive clopidogrel experience reduced platelet inhibition and increased risk for major adverse cardiovascular and cerebrovascular events. Pharmacogenetic testing assists prescribers in selecting tailored treatment and doses that are most effective and avoid those that may cause adverse reactions in an individual with a known genetic variant. This facilitates effective prescription in a clinically relevant timeframe, thereby improving patient outcomes. Now, a rapid point of care (POC) test for CYP2C19 genotyping can effectively guide antiplatelet therapeutics in time-critical settings.

The Genedrive CYP2C19 ID Kit from genedrive plc (Manchester, UK) provides rapid, automated results of CYP2C19 genotypes to inform clinicians on an individual’s metabolizer status according to CPIC guidelines in treatment strategies using therapeutics that are metabolized by CYP2C19. The Genedrive CYP2C19 ID Kit is the only POC genetic test to aid clinicians’ therapeutic treatment decisions for drugs that are metabolized by CYP2C19, and that are specifically affected by DNA variant alleles 2, 3, 4, 8, 17, and 35.

The test provides rapid, actionable results in approximately 69 minutes, including diplotype and CPIC-coded metabolizer status, enabling personalized treatment for antiplatelet therapies. The non-invasive test uses a single buccal swab and has a simple-to-follow workflow. The Genedrive CYP2C19 ID Kit is used in conjunction with the Genedrive System, featuring a compact benchtop design that allows it to be placed at the POC. Designed to be used in time-critical situations, before treatment prescription, it uses gene detection technology​ to provide automated and easy-to-interpret actionable results.

Related Links:
genedrive plc


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Nucleic Acid Purification Instrument
QIAsymphony Connect
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New evidence now questions whether a single stool-test cutoff should be applied uniformly across all age groups.(Photo courtesy of Paul Maguire - Adobe Stock)

Study Questions Uniform Stool-Test Cutoff Across Age Groups

Colorectal cancer remains a major clinical challenge, ranking as the fourth most common cancer and the second-leading cause of cancer death in the U.K. Early-onset colorectal cancer, defined as diagnosis... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.